BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34694567)

  • 1. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.
    Winograd E; Germano I; Wen P; Olson JJ; Ormond DR
    J Neurooncol; 2022 Jun; 158(2):265-321. PubMed ID: 34694567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.
    Germano IM; Ziu M; Wen P; Ormond DR; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):225-253. PubMed ID: 35195819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    Farrell C; Shi W; Bodman A; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.
    Goodman AL; Velázquez Vega JE; Glenn C; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):179-224. PubMed ID: 35648306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.
    Redjal N; Nahed BV; Dietrich J; Kalkanis SN; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):165-213. PubMed ID: 33215343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    Olson JJ; Nayak L; Ormond DR; Wen PY; Kalkanis SN; Ryken TC;
    J Neurooncol; 2014 Jul; 118(3):557-99. PubMed ID: 24740195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults.
    Patrick HH; Sherman JH; Elder JB; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):167-177. PubMed ID: 35246769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
    Johnson DR; Glenn CA; Javan R; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):139-165. PubMed ID: 34694565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bevacizumab in the treatment of glioblastoma.
    Diaz RJ; Ali S; Qadir MG; De La Fuente MI; Ivan ME; Komotar RJ
    J Neurooncol; 2017 Jul; 133(3):455-467. PubMed ID: 28527008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    Olson JJ; Nayak L; Ormond DR; Wen PY; Kalkanis SN;
    J Neurooncol; 2014 Jul; 118(3):501-55. PubMed ID: 24740194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults.
    Ziu M; Goyal S; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):255-264. PubMed ID: 34748120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congress of Neurological Surgeons systematic review and evidence-based guidelines for the treatment of adults with progressive glioblastoma update: introduction and methods.
    Olson JJ
    J Neurooncol; 2022 Jun; 158(2):133-137. PubMed ID: 34694566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Chemotherapy in the Management of Adults With Newly Diagnosed Metastatic Brain Tumors.
    Sherman JH; Lo SS; Harrod T; Hdeib A; Li Y; Ryken T; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E175-E177. PubMed ID: 30629221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lomustine and Bevacizumab in Progressive Glioblastoma.
    Wick W; Gorlia T; Bendszus M; Taphoorn M; Sahm F; Harting I; Brandes AA; Taal W; Domont J; Idbaih A; Campone M; Clement PM; Stupp R; Fabbro M; Le Rhun E; Dubois F; Weller M; von Deimling A; Golfinopoulos V; Bromberg JC; Platten M; Klein M; van den Bent MJ
    N Engl J Med; 2017 Nov; 377(20):1954-1963. PubMed ID: 29141164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
    Cuncannon M; Wong M; Jayamanne D; Guo L; Cove N; Wheeler H; Back M
    BMC Cancer; 2019 May; 19(1):445. PubMed ID: 31088401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy with single agent bevacizumab for recurrent glioblastoma.
    Chamberlain MC; Johnston SK
    J Neurooncol; 2010 Jan; 96(2):259-69. PubMed ID: 19593660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.